• SENSEX 77,966.35
    -187.90 (--0.24%)
  • BANKNIFTY 57,885.85
    439.60 (+0.77%)
  • Tenneco Clean
    524.00 437.85(%)
  • Finolex Cables
    1,375.00 1,375.00(%)
  • Godrej Consumer
    908.00 908.00(%)
  • Max Healthcare
    1,002.00 903.50(%)
  • HDFC Bank
    722.00 722.00(%)
  • TD Power Systems
    1,529.00 1,529.00(%)
  • SBI
    1,085.00 1,234.80(%)
  • Grasim Inds
    3,270.00 2,504.35(%)
  • Hindustan Copper
    569.85 759.20(%)
  • Hindalco Inds.
    1,088.25 1,179.35(%)
  • TCS
    2,301.10 1,976.00(%)
  • Multi Comm. Exc.
    2,987.85 3,479.80(%)
  • Hind.Aeronautics
    5,054.40 5,054.40(%)
  • Fortis Health.
    879.30 767.30(%)
  • Apar Inds.
    18,432.40 18,432.40(%)
  • Axis Bank
    1,216.80 1,041.30(%)
  • Billionbrains
    197.95 227.00(%)
  • Marksans Pharma
    319.90 319.90(%)
  • Ardee Industries
    73.60 73.60(%)
  • LG Electronics
    1,584.00 1,736.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Vilin Bio Med Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 78871.0
  • ISIN : INE0L4V01013
41.90 2 (4.88%)
  • As on 12 Aug 2026 (EOD)
  • Today’s Low

    41.85
  • Today’s High

    41.90
  • Open

    41.85
  • Perv Close

    39.95
  • 52W Low

    18.95
  • 52W High

    54.40

Key Indicators

  • P/E(TTM)

    33.25

  • Mar.Cap (₹Cr.)

    63.90

  • Div & Yield %

    0.00

  • Book Value(₹)

    18.60

  • Debt-Equity Ratio

    4.88

  • AGM Date

    12-Aug-2026

  • EPS

    1.26

  • P/E Ratio

    33.25

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    63.90

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    15.25

  • BV (₹)

    18.60

  • Sales( ₹ in Cr.)

    42.26

  • NP (in Cr.)

    1.93

  • NP Var(%)

    763.0

  • Div%

    0.0

  • CPS (₹)

    1.50

  • EPS (₹)

    1.30

  • Traded Value (₹ in Lakhs)

    63.90

  • 52 Week High

    54.40

  • 52 Week Low

    18.95

  • Price BSE

    0.0

  • Price NSE

    42.00

  • Market Capital( in Cr.)

    63.90

  • P/C Ratio

    28.90

  • P/E Ratio

    33.20

  • Price Vs.BV

    1.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 14.81 15.80 12.31 11.21 11.72 16.81
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 14.81 15.80 12.31 11.21 11.72 16.81
Other Income 0.47 0.32 0.02 0.00 0.00 0.01
Stock Adjustments 0.00 -0.21 -0.08 0.01 0.02 0.20
Total Income 15.28 15.91 12.25 11.22 11.74 17.02
EXPENDITURE :            
Raw Materials 13.47 12.80 7.10 8.88 9.06 13.92
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.20 0.22
Employee Cost 0.30 0.80 0.78 0.85 0.91 1.20
Other Manufacturing Expenses 0.02 0.02 0.09 0.33 0.13 0.10
Selling and Administration Expenses 0.21 0.36 1.33 0.40 0.61 0.61
Miscellaneous Expenses 0.03 0.80 0.37 0.00 -0.02 0.06
Employee Benefit Expenses 0.30 0.80 0.78 0.85 0.91 1.20
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 14.02 14.78 9.67 10.46 10.88 16.11
Operating Profit 1.26 1.15 2.60 0.77 0.86 0.92
Interest 0.85 0.79 0.65 0.51 0.44 0.41
Gross Profit 0.41 0.36 1.95 0.26 0.42 0.51
Depreciation 0.10 0.13 0.17 0.22 0.26 0.31
Profit Before Tax 0.31 0.23 1.78 0.04 0.16 0.20
Current Tax 0.07 0.05 0.53 0.01 0.04 0.04
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.01 0.01 0.01 0.00 0.00 0.00
Reported Net Profit 0.22 0.16 1.25 0.03 0.12 0.16
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.22 0.16 1.25 0.03 0.12 0.16
Adjustment below Net Profit 0.00 0.00 -4.61 0.00 0.00 0.00
P & L Balance brought forward 0.66 0.50 3.87 3.84 3.72 3.55
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 0.89 0.66 0.50 3.87 3.84 3.72
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.16 0.12 1.25 0.10 0.37 0.49
Earnings Per Share(Adj)-Unit Curr 0.16 0.12 - - - -
Book Value 16.53 16.37 10.73 22.41 22.31 21.94
Book Value(Adj)-Unit Curr 16.53 16.37 - - - -

Shareholding Pattern

  • Promoter Group

    56.65%

  • Public Share Holding

    43.35%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 8,638,574 56.65 8,638,574 13
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 8,638,574 56.65 8,638,574 13
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 1,304,000 8.55 1,304,000 3
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 60,000 0.39 60,000 10
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 194,000 1.27 194,000 19
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,319,425 8.65 1,319,425 3
Individuals holding nominal share capital up to Rs. 1 lakh 3,726,001 24.43 3,726,001 333
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 8,000 0.05 8,000 1
Sub Total 6,611,426 43.35 6,611,426 369
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 15,250,000 100.00 15,250,000 382

Company Background

Vilin Bio Med LtdPharmaceuticals - Indian - Bulk Drugs

  • Vilin Bio Med Ltd
  • BSE Code : 78871.0
  • ISIN : INE0L4V01013
  • Incorporation Year

    2005

  • Registered Office

    Sy #115/GF/J Hanumanji Colony
    Brig Sayeed Rd Bowempally, Secunderabad,
    Telangana-500003

  • Telephone

    +91 40 7961 8843

  • FAX

  • Chairman

  • Managing Director

    MADHUSUDHAN YADAMAKANTI REDDY

  • Company Secretary

    Dhruv Vishwanath Todi.

  • Auditor

    PPKG & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Vilin Bio Med Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Vilin Bio Med 41.90 15.28 14.81 33.25 4.16
Abbott India 28,146.90 7,217.19 6,929.05 38.54 43.78
Astrazeneca Phar 7,905.70 2,304.07 2,275.58 116.52 27.86
P & G Health Ltd 5,953.30 944.52 934.17 27.69 71.75
Glaxosmi. Pharma 2,619.65 3,932.76 3,790.20 41.85 58.17
Cipla 1,461.55 20,102.60 18,979.95 38.41 13.88
Bliss GVS Pharma 488.20 773.53 729.81 53.53 12.51
Amrutanjan Healt 487.20 469.50 451.82 24.32 21.89
Fermenta Biotec. 473.40 474.15 450.25 21.68 18.77
Guj. Themis Bio. 352.85 152.47 150.80 78.94 27.21
Ambalal Sarabhai 44.93 19.52 3.94 31.42 6.77